Drug Eluting Stents: An Update With a Focus on Safety

Does Meet CTAF Criteria

This topic was reviewed by the California Technology Assessment Forum on February 28, 2007. The panel determined that:

Drug-eluting stents be implanted only in patients who meet current FDA labeling criteria.


Full Assessment:

Download (PDF, 169 KB)

Search Assessments

Email Notification

Sign up to receive email notifications of upcoming CTAF meetings and new assessments.

 

Methodology

Learn about the CTAF criteria used to evaluate a new or emerging technology.

Criteria used »
Assessment Process »
Format of Report »

Suggest an Assessment

Know of a new device, procedure, or test that CTAF should consider for assessment?

Contact us »
 
© 2008 California Technology Assessment Forum. All rights reserved.

Contact Us | Privacy Policy | Terms of Use | Credits